-
Press Release
Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis
-
Story
How collaboration can enhance your science career -
Story
The art of drug design in a technological age -
Press Release
Novartis research shows technology talent increasingly drawn to pharma industry since COVID-19, to solve healthcare challenges
-
Story
Digital innovation looks set to dominate the 2021 healthcare agenda -
Story
AI is changing the face of healthcare -
Story
Predictive analytics could bring medicines to patients faster -
Story
Meet Achim, leading the data42 program -
Story
The data42 program shows Novartis’ intent to go big on data and digital -
Story
COVID-19: Answering your top questions